18 employees
MaxWell Biosciences is biotechnology for optimizing cognitive performance and health span.
2016
$11M
from 3 investors over 3 rounds
Maxwell Biosciences raised $11M on March 10, 2022
Investors: DecentraNet and Keiretsu Forum / Capital
Maxwell Biosciences raised undisclosed on October 1, 2021
Investors: Longevitytech.fund